- Home
- BZH vs APLT Comparison
BZH vs APLT Comparison
Compare BZH & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZH
- APLT
- Stock Information
- Founded
- BZH 1985
- APLT 2016
- Country
- BZH United States
- APLT United States
- Employees
- BZH N/A
- APLT N/A
- Industry
- BZH Homebuilding
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- BZH Consumer Discretionary
- APLT Health Care
- Exchange
- BZH Nasdaq
- APLT Nasdaq
- Market Cap
- BZH 666.1M
- APLT 42.5M
- IPO Year
- BZH 1994
- APLT 2019
- Fundamental
- Price
- BZH $23.09
- APLT $0.33
- Analyst Decision
- BZH Strong Buy
- APLT Buy
- Analyst Count
- BZH 3
- APLT 7
- Target Price
- BZH $33.00
- APLT $6.10
- AVG Volume (30 Days)
- BZH 332.4K
- APLT 2.1M
- Earning Date
- BZH 07-31-2025
- APLT 08-06-2025
- Dividend Yield
- BZH N/A
- APLT N/A
- EPS Growth
- BZH N/A
- APLT N/A
- EPS
- BZH 3.10
- APLT N/A
- Revenue
- BZH $2,436,131,000.00
- APLT $265,000.00
- Revenue This Year
- BZH N/A
- APLT $1,768.13
- Revenue Next Year
- BZH $14.27
- APLT $292.85
- P/E Ratio
- BZH $7.22
- APLT N/A
- Revenue Growth
- BZH 13.50
- APLT N/A
- 52 Week Low
- BZH $17.37
- APLT $0.30
- 52 Week High
- BZH $38.22
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- BZH 57.43
- APLT 42.58
- Support Level
- BZH $21.73
- APLT $0.30
- Resistance Level
- BZH $22.84
- APLT $0.39
- Average True Range (ATR)
- BZH 0.75
- APLT 0.03
- MACD
- BZH 0.02
- APLT 0.00
- Stochastic Oscillator
- BZH 61.61
- APLT 21.64
About BZH Beazer Homes USA Inc.
Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in over 13 states and over 22 metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the leading sources of revenue for the company. Key metro areas include Atlanta, Las Vegas, Los Angeles, Orlando, and Tampa. The company also focuses on land purchasing and development to support future construction efforts as well as mortgage services for its homebuyers.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.